Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMMED ABUBAKER

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1396733796
CMS profile
63191
Location
MARIETTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$15,614.37

227 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 227 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMMED ABUBAKER

NPI 1396733796 · CMS profile ID 63191

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

MARIETTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 227 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396733796?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMMED ABUBAKER, NPI 1396733796, CMS profile ID 63191. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 227 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396733796?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). MOHAMMED ABUBAKER, NPI 1396733796, CMS profile ID 63191. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 227 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396733796?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
MOHAMMED ABUBAKER, NPI 1396733796, CMS profile ID 63191, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 227 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1396733796?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

227 matching records · $15,614.37 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 227 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 227.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $19.4910/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125044638 CMS
Amgen Inc. $12.9910/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115408231 CMS
Lilly USA, LLC $20.5710/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135219580 CMS
UCB, Inc. $23.3110/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143162032 CMS
ABBVIE INC. $6.7010/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170364 CMS
Aurinia Pharma U.S., Inc. $26.9910/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150674297 CMS
Janssen Biotech, Inc. $29.1210/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078545968 CMS
Genentech USA, Inc. $30.1410/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133074873 CMS
PFIZER INC. $20.5710/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132093070 CMS
Janssen Biotech, Inc. $21.5310/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078547728 CMS
UCB, Inc. $0.8109/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143162028 CMS
UCB, Inc. $28.2309/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143162030 CMS
AstraZeneca Pharmaceuticals LP $18.6909/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105869887 CMS
GlaxoSmithKline, LLC. $18.8609/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116606558 CMS
ABBVIE INC. $17.4209/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170362 CMS
ANI Pharmaceuticals, Inc. $17.6409/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091172358 CMS
Novartis Pharmaceuticals Corporation $27.7109/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667419 CMS
ABBVIE INC. $8.5109/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170358 CMS
ABBVIE INC. $18.6209/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170360 CMS
Janssen Biotech, Inc. $23.2209/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078547381 CMS
Janssen Biotech, Inc. $0.9409/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078548263 CMS
ANI Pharmaceuticals, Inc. $25.3309/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091157864 CMS
ABBVIE INC. $18.6109/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170354 CMS
ABBVIE INC. $6.6509/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170356 CMS
GlaxoSmithKline, LLC. $10.3509/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116657077 CMS
ABBVIE INC. $2,125.0009/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103137481 CMS
Amgen Inc. $30.5308/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115408276 CMS
Novartis Pharmaceuticals Corporation $29.9508/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667427 CMS
Novartis Pharmaceuticals Corporation $1.8208/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667431 CMS
Amgen Inc. $7.5108/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115408227 CMS
GlaxoSmithKline, LLC. $29.1908/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115856941 CMS
ABBVIE INC. $13.5708/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170352 CMS
Janssen Biotech, Inc. $24.7208/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078546138 CMS
Janssen Biotech, Inc. $0.9008/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078547293 CMS
ABBVIE INC. $6.2608/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170350 CMS
Janssen Biotech, Inc. $26.3408/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078547888 CMS
Novartis Pharmaceuticals Corporation $1.4308/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667425 CMS
Novartis Pharmaceuticals Corporation $3.4808/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667429 CMS
AstraZeneca Pharmaceuticals LP $21.6408/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104424657 CMS
PFIZER INC. $19.0408/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131834842 CMS
Janssen Biotech, Inc. $19.7908/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078547590 CMS
ABBVIE INC. $4.0108/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170344 CMS
ABBVIE INC. $124.4208/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170346 CMS
ABBVIE INC. $21.9808/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103170348 CMS
Novartis Pharmaceuticals Corporation $29.9108/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086667411 CMS
ANI Pharmaceuticals, Inc. $22.0508/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091164820 CMS
SOBI, INC $19.2507/31/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141425235 CMS
UCB, Inc. $9.4907/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143162026 CMS
Actelion Pharmaceuticals US, Inc. $14.7807/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078883981 CMS
GlaxoSmithKline, LLC. $20.2107/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116193171 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $80,623.74 339
PY2020 $51,733.44 210
PY2021 $24,332.51 198
PY2022 $27,087.95 244
PY2023 $15,960.29 218
PY2024 $15,614.37 227
PY2025 $3,095.01 134

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Principal investigator $46,232.67 4
PY2019 Principal investigator $66,420.82 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca UK Limited $11,923.97 12/31/2020 Non-covered Recipient Entity
Marietta Rheumatology Associates, Pc
The purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre Randomised Double blind Placebo Controlled Phase 3 Extension Study to Characterise the Long term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus No dispute reported 06/30/2026 736735245
Principal investigator 1 AstraZeneca UK Limited $4,429.00 03/30/2020 Non-covered Recipient Entity
Marietta Rheumatology Associates, Pc
The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of two doses of anifrolumab versus placebo in adult subjects with moderately to severely active autoantibody positive systemic lupus erythematosus SLE No dispute reported 06/30/2026 736741919
Principal investigator 1 AstraZeneca UK Limited $28,867.00 01/27/2020 Non-covered Recipient Entity
Marietta Rheumatology Associates, Pc
The purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre Randomised Double blind Placebo Controlled Phase 3 Extension Study to Characterise the Long term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus No dispute reported 06/30/2026 736736087
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,012.70 01/17/2020 Non-covered Recipient Entity
Marietta Clinical Research, Incorporated
Opt-Phase IV H2H MOA Inhibition of joint damage patients - Orencia vs Humira Week 24 DBL No dispute reported 06/30/2026 736760597